BWA
TNDM icon

Basecamp Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Basecamp Wealth Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$550 – 2164
2025
Q4 		$550 Buy
+25
New +$451 ﹤0.01% 1618

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Basecamp Wealth Advisors's TNDM Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 25 shares — an estimated $550 sold.

Basecamp Wealth Advisors first reported a position in TNDM in Q4 2025 and held it in 1 quarter. The position peaked at $550 in Q4 2025. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Basecamp Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 25 Tandem Diabetes Care shares in Q1 2026, an estimated $550.
  • Basecamp Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2025 and held it in 1 quarter.
  • Basecamp Wealth Advisors's Tandem Diabetes Care position peaked at $550 in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.